DNA polymerase β variant Ile260Met generates global gene expression changes related to cellular transformation

Mutagenesis

Volumn 27, Issue 6, 2012, Pages 683-691

  Donigan, Katherine A ^a   Tuck, David ^a   Schulz, Vince ^a   Sweasy, Joann B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; DNA DIRECTED DNA POLYMERASE BETA; LYMPHOCYTE ANTIGEN; MATRIX METALLOPROTEINASE 19; NECTIN 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THROMBOSPONDIN 1; TROGLITAZONE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL JUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; DOWN REGULATION; EXON; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE PRODUCT; GENETIC CODE; GENETIC MANIPULATION; GLUCONEOGENESIS; INSULIN RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; DNA; DNA COPY NUMBER VARIATIONS; DNA POLYMERASE BETA; DNA REPAIR; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GENOMIC INSTABILITY; MICE; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME;

EID: 84867657767     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges034     Document Type: Article

References (45)

1. Loeb, L. A., Bielas, J. H. and Beckman, R. A. (2008) Cancers exhibit a mutator phenotype: clinical implications. Cancer Res. 68, 3551-3557; discussion 3557.
2. Sjoblom, T., Jones, S., Wood, L. D. et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-274.
3. Wood, L. D., Parsons, D. W., Jones, S. et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science, 318, 1108-1113.
4. Salk, J. J., Fox, E. J. and Loeb, L. A. (2010) Mutational heterogeneity in human cancers: origin and consequences. Annu. Rev. Pathol. 5, 51-75.
5. Lindahl, T. and Wood, R. D. (1999) Quality control by DNA repair. Science, 286, 1897-1905.
6. Beard, W. A. and Wilson, S. H. (2000) Structural design of a eukary-otic DNA repair polymerase: DNA polymerase beta. Mutat. Res. 460, 231-244.
7. Dobashi, Y., Shuin, T., Tsuruga, H., Uemura, H., Torigoe, S. and Kubota, Y. (1994) DNA polymerase beta gene mutation in human prostate cancer. Cancer Res. 54, 2827-2829.
8. Starcevic, D., Dalal, S. and Sweasy, J. (2005) Hinge residue Ile260 of DNA polymerase beta is important for enzyme activity and fidelity. Biochemistry, 44, 3775-3784.
9. Yamtich, J., Starcevic, D., Lauper, J., Smith, E., Shi, I., Rangarajan, S., Jaeger, J. and Sweasy, J. B. Hinge residue I174 is critical for proper dNTP selection by DNA polymerase beta. Biochemistry, 49, 2326-2334.
10. Starcevic, D., Dalal, S., Jaeger, J. and Sweasy, J. B. (2005) The hydropho-bic hinge region of rat DNA polymerase beta is critical for substrate binding pocket geometry. J. Biol. Chem. 280, 28388-28393.
11. Dalal, S., Hile, S., Eckert, K. A., Sun, K. W., Starcevic, D. and Sweasy, J. B. (2005) Prostate-cancer-associated Ile260Met variant of DNA polymerase beta is a sequence-specific mutator. Biochemistry, 44, 15664-15673.
12. Sweasy, J. B., Lang, T., Starcevic, D., Sun, K. W., Lai, C. C., Dimaio, D., and Dalal, S. (2005) Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation. Proc. Natl. Acad. Sci. USA, 102, 14350-14355.
13. Law, M. F., Lowy, D. R., Dvoretzky, I. and Howley, P. M. (1981) Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc. Natl Acad. Sci. USA, 78, 2727-2731.
14. Leach, E. G., Gunther, E. J., Yeasky, T. M., Gibson, L. H., Yang-Feng, T. L. and Glazer, P. M. (1996) Frequent spontaneous deletions at a shuttle vector locus in transgenic mice. Mutagenesis, 11, 49-56.
15. Ashburner, M., Ball, C. A., Blake, J. A. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29.
16. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
17. Gautier, L., Cope, L., Bolstad, B. M. and Irizarry, R. A. (2004) Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307-315.
18. Yu, T., Ye, H., Sun, W., Li, K. C., Chen, Z., Jacobs, S., Bailey, D. K., Wong, D. T. and Zhou, X. (2007) A forward-backward fragment assembling algorithm for the identification of genomic amplification and deletion breakpoints using high-density single nucleotide polymorphism (SNP) array. BMC Bioinformatics, 8, 145.
19. Nicol, J. W., Helt, G. A., Blanchard, S. G., Jr., Raja, A. and Loraine, A. E. (2009) The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics, 25, 2730-2731.
20. Suzuki, S., Sasaki, S., Morita, H., Oki, Y., Turiya, D., Ito, T., Misawa, H., Ishizuka, K. and Nakamura, H. (2010) The role of the amino-terminal domain in the interaction of unliganded peroxisome proliferator-activated receptor gamma-2 with nuclear receptor co-repressor. J. Mol. Endocrinol. 45, 133-145.
21. Hayes, J. D. and Pulford, D. J. (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30, 445-600.
22. Ellsworth, R. E., Seebach, J., Field, L. A., Heckman, C., Kane, J., Hooke, J. A., Love, B. and Shriver, C. D. (2009) A gene expression signature that defines breast cancer metastases. Clin. Exp. Metastasis, 26, 205-213.
23. Bell, E., Chen, L., Liu, T., Marshall, G. M., Lunec, J. and Tweddle, D. A. (2010) MYCN oncoprotein targets and their therapeutic potential. Cancer Lett. 293, 144-157.
24. Simantov, R. and Silverstein, R. L. (2003) CD36: a critical anti-angiogenic receptor. Front Biosci. 8, s874-8 82.
25. Welch, C., Santra, M. K., El-Assaad, W., Zhu, X., Huber, W. E., Keys, R. A., Teodoro, J. G. and Green, M. R. (2009) Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer Res. 69, 6782-6789.
26. Chan, K. C., Ko, J. M., Lung, H. L. et al. (2010) Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Int. J. Cancer 2010 December 16 [Epub ahead of print], doi:10.1002/ijc.25855.
27. Jostarndt, K., Rubic, T., Kuhn, H. et al. (2004) Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way. Biochem. Pharmacol. 67, 841-854.
28. Moore, K. J., Rosen, E. D., Fitzgerald, M. L. et al. (2001) The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat. Med. 7, 41-47.
29. Jitrapakdee, S., Slawik, M., Medina-Gomez, G., Campbell, M., Wallace, J. C., Sethi, J. K., O'Rahilly, S. and Vidal-Puig, A. J. (2005) The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxy-lase gene expression in vivo and in vitro. J. Biol. Chem. 280, 27466-27476.
30. Ito, M., Nagasawa, M., Hara, T., Ide, T. and Murakami, K. (2010) Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes. J. Lipid Res. 51, 1676-1684.
31. Kim, Y. J., Cho, S. Y., Yun, C. H., Moon, Y. S., Lee, T. R. and Kim, S. H. (2008) Transcriptional activation of Cidec by PPARgamma2 in adipocyte. Biochem. Biophys. Res. Commun. 377, 297-302.
32. Zandbergen, F., Mandard, S., Escher, P. et al. (2005) The G0/G1 switch gene 2 is a novel PPAR target gene. Biochem. J., 392, 313-324.
33. Rosenberg, B. R., Hamilton, C. E., Mwangi, M. M., Dewell, S. and Papavasiliou, F. N. (2011) Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3 UTRs. Nat. Struct. Mol. Biol., 18, 230-236.
34. Ashur-Fabian, O., Har-Zahav, A., Shaish, A. et al. (2010) apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53. Cell Cycle, 9, 3761-3770.
35. Satoh-Horikawa, K., Nakanishi, H., Takahashi, K., Miyahara, M., Nishimura, M., Tachibana, K., Mizoguchi, A. and Takai, Y. (2000) Nectin-3, a new member of immunoglobulin-like cell adhesion molecules that shows homophilic and heterophilic cell-cell adhesion activities. J. Biol. Chem., 275, 10291-10299.
36. Suh, Y. A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K. and Lambeth, J. D. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature, 401, 79-82.
37. Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S. and Reddy, J. K. (1995) Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc. Natl Acad. Sci. USA, 92, 7921-7925.
38. Stumvoll, M. and Haring, H. (2002) The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes, 51, 2341-2347.
39. Braissant, O., Foufelle, F., Scotto, C., Dauca, M. and Wahli, W. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and-gamma in the adult rat. Endocrinology, 137, 354-366.
40. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. and Spiegelman, B. M. (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev., 8, 1224-1234.
41. Werman, A., Hollenberg, A., Solanes, G., Bjorbaek, C., Vidal-Puig, A. J. and Flier, J. S. (1997) Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and-2 isoforms and influence of insulin. J. Biol. Chem., 272, 20230-20235.
42. Brockman, J. A., Gupta, R. A. and Dubois, R. N. (1998) Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology, 115, 1049-1055.
43. Ameshima, S., Golpon, H., Cool, C. D. et al. (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ. Res., 92, 1162-1169.
44. Starcevic, D., Dalal, S. and Sweasy, J. B. (2004) Is there a link between DNA polymerase beta and cancer? Cell Cycle, 3, 998-1001.
45. Lang, T., Dalal, S., Chikova, A., DiMaio, D. and Sweasy, J. B. (2007) The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation. Mol. Cell Biol., 27, 5587-5596.